JAMIE THOMPSON: Open Payments
NPI 1902041981 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,652 in 128 payments from 24 companies in 2025. Trend: 2023 $1,591 · 2024 $2,486 · 2025 $7,652
Food & beverage: $3,615Travel & lodging: $2,197Consulting: $1,750Education: $90
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $3,684 |
| Medtronic, Inc. | 9 | $1,161 |
| ABBVIE INC. | 22 | $426 |
| Janssen Biotech, Inc. | 14 | $407 |
| Madrigal Pharmaceuticals | 9 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $228 |
| Gilead Sciences, Inc. | 11 | $201 |
| Boston Scientific Corporation | 1 | $149 |
| Ipsen Biopharmaceuticals, Inc | 6 | $147 |
| Celltrion USA Inc. | 4 | $140 |
Products named: TRULANCE, INTERSTIM, XIFAXAN, TREMFYA, REZDIFFRA, TheraSphere Administration Set, MAVYRET, IQIRVO.
Industry payments across CO — which companies pay providers there.
